Title Marketing of Clozaril : improved safety or barrier to access : hearing before the Subcommittee on Antitrust, Monopolies and Business Rights of the Committee on the Judiciary, United States Senate, One Hundred Second Congress, first sessionon the marketing of Clozaril, a drug for the treatment of schizophrenia, March 5, 1991.

Publication Info.

Item Status

Location	Call No.	Status	OPAC Message	Public Note	Gift Note
Moore Stacks	5009	Available	---

Description	iii, 139 pages ; 24 cm.
Physical Medium	4x6 in.
	monochrome
	service copy
	negative
Series	S. hrg. ; 102-175
	United States. Congress. Senate. S. hrg. ; 102-175.
Note	"Serial no. J-102-6."
Bibliography	Includes bibliographical references.
Reproduction	Microfiche. Washington : U.S. G.P.O., 1992. 2 microfiches : negative ; 11 x 15 cm.
Note	s 1992 dcu n b
Subject	Clozapine -- Marketing.
	Clozapine.
	Marketing.
	Drugs -- Prices -- United States.
	Drugs -- Prices.
	United States.
	Medical care -- United States -- Cost control.
	Medical care.
	Cost control.
	Sandoz Pharmaceuticals Corporation.
	Sandoz Pharmaceuticals Corporation.
	Medication.
	Medical care.
Gpo Item No.	1042-B
Sudoc No.	Y 4.J 89/2:S.hrg.102-175